Abstract: A system and method for visual image compression and transmission offers significant bandwidth conservation while retaining high resolution imaging capability. Videograpic images are decomposed into detail levels, and images are delivered to a remote site display at a level of detail proportional to the perception level of a viewer. Images are transformed, quantized, coded and queued for transmission in accordance with their level of image detail. Image detail layers are transmitted as an inverse function of image displacement speed and as a direct function of image magnification. Images are constructed vertically with each additional queueing layer providing additional image detail. Higher priority layers are lossy encoded, while the lowest priority layers (highest detail levels) are losslessly encoded.
Abstract: Human lipocortins III, IV, V and VI, DNA sequences and recombinant DNA molecules that are characterized in that they code for these human lipocortins. Hosts transformed with these sequences may be employed in the processes of this invention to produce the human lipocortin molecules of this invention. These polypeptides possess anti-inflammatory activity and are useful in the treatment of arthritic, allergic, dermatologic, ophthalmic and collagen diseases.
Type:
Grant
Filed:
March 13, 1991
Date of Patent:
March 29, 1994
Assignee:
Biogen, Inc.
Inventors:
Barbara P. Wallner, R. Blake Pepinsky, Jeffrey L. Browning
Abstract: Synthetic linear or cyclic peptides having the formula[A].sub.x -[B].sub.x -Ser-Ser-Ser-Asn-Tyr-[C].sub.xwhereinA is L-Ala, DL-Ala, D-Ala, Gly, or Val;B is L-Ala, DL-Ala, D-Ala, Gly, or Val;C is L-Met, L-Met (O), Cys, Thr or Gly; andx is an integer of from 0-1.A method of treating AIDS by administering the synthetic peptides is also provided.
Abstract: DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human lipocortin-like polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human lipocortin-like polypeptide. In appropriate hosts these DNA sequences permit the production of human lipocortin-like polypeptides useful as anti-inflammatory agents and methods in the treatment of arthritic, allergic, dermatologic, ophthalmic and collagen diseases as well as other disorders involving inflammatory processes.
Type:
Grant
Filed:
January 10, 1986
Date of Patent:
August 21, 1990
Assignee:
Biogen, Inc.
Inventors:
Barbara P. Wallner, R. Blake Pepinsky, Jeffrey L. Garwin, Daniel G. Schindler, Kuo-Sen Huang
Abstract: DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human phospholipase inhibitor polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human phospholipase inhibitor polypeptide. In appropiate hosts these DNA sequences permit the production of human phospholipase inhibitor polypeptides.
Type:
Grant
Filed:
January 10, 1985
Date of Patent:
November 7, 1989
Assignee:
Biogen, Inc.
Inventors:
Barbara P. Wallner, R. Blake Pepinsky, Jeffrey L. Garwin
Abstract: DNA sequences, recombinant DNA molecules and hosts transformed with them which produce human phospholipase inhibitor-like polypeptides and methods of making and using these products. The DNA sequences and recombinant DNA molecules are characterized in that they code on expression for a human phospholipase inhibitor-like polypeptide. In appropriate hosts these DNA sequences permit the production of human phospholipase inhibitor-like polypeptides useful as anti-inflammatory agents and methods in the treatment of arthritic, allergic, dermatologic, ophthalmic and collagen diseases as well as other disorders involving inflammatory processes.
Type:
Grant
Filed:
March 15, 1985
Date of Patent:
October 17, 1989
Assignee:
Biogen, Inc.
Inventors:
Barbara P. Wallner, R. Blake Pepinsky, Jeffrey L. Garwin